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This is the first study to report on the determination of Sb species in urine. To this end, HPLC was coupled
online to an ICP-MS instrument using ultrasonic nebulization (USN) or hydride generation (HG) for sample
introduction into the ICP-MS. The high chloride concentration in urine seriously hampered the
chromatographic separation of Sb(V) and Sb(III) on the Dionex AS14 anion exchange column. Distinct signal
suppression, shifting of retention times and severe peak broadening did not allow the application to urine
samples. Progress to avoid these problems in HPLC-USN-ICP-MS could be made by employing a Hamilton
PRP-X100 anion-exchange column. However, Na eluting in the void volume of the column gave rise to a
Na-induced peak overlapping with the Sb(V) signal when USN was used to aspirate the HPLC eluents into the
plasma. Therefore, a HG system was placed between the HPLC and ICP-MS instrumentation to overcome this
dilemma. Thus, Sb(V) and Sb(III) were separated in urine with the PRP-X100 column using 20 mM EDTA at
pH 4.7 as the mobile phase. Similarly, an ION-120 anion-exchange column was employed to separate
trimethylantimony dichloride (TMSbCl2) and Sb(V) with a mobile phase containing 2 mM NH4HCO3 and
1 mM tartaric acid at pH 8.5. Detection limits of 20 ng l21, 12 ng l21 and 8 ng l21 for Sb(V), TMSbCl2 and
Sb(III), respectively, could be established in a 1z2 diluted urine matrix. The developed HPLC-HG-ICP-MS
method was applied to the speciation of Sb in the urine of occupationally exposed and non-exposed subjects.
Additionally, two lyophilised urine reference materials were investigated. Sb(V) was by far the predominant Sb
species, followed by TMSbCl2. Only ultratraces of Sb(III), if any detectable, could be found. The sum of the
concentrations of Sb(V), Sb(III) and TMSbCl2 in urine samples ranged between 51 and 78% of their total Sb
concentrations.
Introduction
Speciation analysis of antimony in environmentally relevant
areas increasingly attracts the scientific community. Although
distinct drawbacks hamper the application of speciation
procedures for Sb, tremendous improvements have been
accomplished during recent years.1 The growing interest in
Sb speciation is documented in particular by a growing number
of publications, including three reviews published on the issue
during the last five years.1–3
Speciation analysis of Sb in aqueous systems is convention-
ally performed by high-performance liquid chromatography
(HPLC) coupled online with adequate element-specific detec-
tion, such as hydride generation-atomic absorption spectro-
metry (HG-AAS), inductively coupled plasma atomic emission
spectrometry (ICP-AES) or inductively coupled plasma mass
spectrometry (ICP-MS).1–3 The lowest detection limits
reported for the determination of Sb species by HPLC-HG-
AAS are in the range of 1 mg l21, namely 0.4 mg l21 for
trimethylantimony dichloride (TMSbCl2), 0.7 mg l
21 for Sb(III)
and 1.0 mg l21 for Sb(V).4 Employing HPLC-ICP-MS, these
values can be lowered about 100 times, thus detection limits in
the low ng l21 can be realised.5,6
A major problem encountered with the speciation of Sb in
real samples consists of the generally low extraction yield for
Sb. Quite frequently, only a few per cent. of the total Sb could
be released from the matrix.6 Thus most of the Sb species
information is retained within the samples and Sb speciation
procedures are not that useful in gaining further knowledge
about the fate of Sb in environmental specimens.
The direct analysis of liquids such as urine, without requiring
any extraction of Sb, might be advantageous in studying the
occurrence and metabolism of Sb species in certain cases.
Moreover, it would allow regular human biomonitoring with
respect to these compounds of concern. However, high matrix
loads in urine, which are normally not present in extracts of
solid samples, may hamper this endeavour. Moreover, total Sb
concentrations in urine of non-exposed persons are below
1 mg l21.7 Therefore, only analytical procedures with detection
limits in the low ng l21 range can be utilised for the
identification of Sb species in urine.
Based on our previously reported set-up utilising HPLC-
HG-AAS4 and HPLC-ICP-MS6 for the speciation of Sb(V),
Sb(III) and TMSbCl2 in aqueous standard solutions, this study
was intended to develop reliable speciation procedures for Sb
compounds in the urine of occupationally non-exposed and




The high-performance liquid chromatographic (HPLC) system
consisted of a metal-free pump (L-6220 Intelligent Pump,
Merck, Darmstadt, Germany), a Rheodyne metal-free six-port
injector valve with a 100 ml sample loop made from polyether
ether ketone (PEEK), and one of the anion-exchange columns
listed in Table 1. All tubings of the chromatographic device
coming into contact with the mobile phase were made from
inert PEEK material. Eluents of the chromatographic system
were aspirated into the plasma of the ICP-MS (Elan 5000,
Perkin Elmer, Norwalk, CT, USA) with an ultrasonic nebulizer
(USN) equipped with a membrane desolvation unit
(U-6000ATz, Cetac Technologies, Omaha, NE, USA). For
HPLC-hydride generation (HG)-ICP-MS measurements, a
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commercial hydride generation system (FIAS 400, Perkin
Elmer), already previously adapted for the online coupling of
HPLC to HG-AAS,4 was utilised. HPLC eluents were mixed
with adequate solutions of HCl and NaBH4, and the thus
formed gaseous hydrides were transported by a stream of argon
via a cross-flow nebulizer into the spray chamber of the
ICP-MS. The signal (121Sb) of the mass spectrometer was
recorded with a sampling rate of 1 point s21 with the time-
resolved software of the ICP-MS. Chromatographic data were
processed with Origin 5.0 (Microcal Software, Inc., North-
ampton, MA, USA). Detailed operating conditions of the
HPLC-USN-ICP-MS and of the HPLC-HG-ICP-MS systems
as well as specifications of the anion-exchange columns used in
this study are summarised in Table 1.
Reagents and standards
For the preparation of all solutions, MilliQ water (Millipore,
Milford, MA, USA) was used. The mobile phases for HPLC
were prepared by dissolution of appropriate amounts of
ethylenediamine tetraacetic acid (puriss. p.a., Fluka, Neu-
Ulm, Switzerland) or ammonium hydrogen carbonate (Fluka,
MicroSelect) and tartaric acid (Fluka, MicroSelect) in MilliQ
water. Adjustment of pH values was made with an ammonia
solution (25%, suprapur1, Merck, Darmstadt, Germany).
Corresponding chromatographic investigations have been
extensively reported earlier.4 Briefly, among the five anion-
exchange columns tested, the Dionex AS14 provided best
results for the separation of Sb(V) and Sb(III) with 1.25 mM
EDTA at pH 4.7. The ION-120 column was used to separate
TMSb and Sb(V) with 2 mM NH4HCO3 and 1 mM tartaric
acid at pH 8.5.
Two 1000 mg l21 stock solutions of Sb(III) and Sb(V) were
prepared by dissolving appropriate amounts of potassium
antimony tartrate (Sigma-Aldrich Chemie GmbH, Steinheim,
Germany) and potassium hexahydroxyantimonate (Fluka) in
high-purity water. A 100 mg l21 stock solution of trimethy-
lantimony dichloride (TMSbCl2) was prepared similarly.
TMSbCl2 was kindly donated by H.J. Breunig, University of
Bremen, Germany. All stock standard solutions were stored in
polyethylene bottles in a refrigerator held at 6 ‡C. These
solutions were stable for at least 12 months.
Sodium chloride (suprapur1) and silver nitrate (analytical-
reagent grade) were purchased from Merck. The quality and
type of acids employed for the open vessel digestion procedure,
as well as of the reagents used for hydride generation, have
been reported earlier.7
Urine samples
Spot urine samples from two unexposed persons and from two
occupationally exposed workers in the battery producing
industry were collected into Sb-free polyethylene tubes.
Additionally, two lyophilised urine reference materials,
namely SRM 2670 (NIST, Gaithersburg, MD, USA) and
Seronorm Batch No. 403125 (Nycomed, Oslo, Norway) were
analysed. Both freeze-dried reference materials were recon-
stituted with high-purity water, as recommended by the
manufacturers. All urine samples were kept at 4 ‡C until
analysis.
Analytical procedures
Determination of total Sb concentration. A slightly modified
procedure in comparison to that developed previously for plant
and lipid-rich materials7 was used for the determination of total
Sb in urine. It is based on open vessel digestion followed by
hydride generation atomic absorption spectrometry
(HG-AAS). Three ml of urine were mineralised with 0.5 ml
sulfuric acid, 3 ml nitric acid, 0.5 ml perchloric acid and 0.1 ml
hydrofluoric acid in digestion vessels made of glassy carbon in
an aluminium heating block. Digestion solutions were diluted
to 10 ml with 10% (w/v) HCl. After addition of 1 ml of the
reduction solution (30% KI and 5% ascorbic acid) to the
diluted digests, they were subjected to HG-AAS as described in
detail elsewhere.7,8
Speciation analysis. The only sample pretreatment of urine
samples involved plain dilution and filtration before the urine
was injected into the HPLC-ICP-MS. Depending on the
concentration of Sb species in urine, samples were diluted from
1z2 to up to 1z49 with the mobile phase employed for the
chromatographic separation. Samples were filtered through
0.2 mm Minisart RC 25 filters (Satorius, Go¨ttingen, Germany)
before injection of the urine onto the chromatographic column.
The species TMSbCl2 in urine samples cannot be unequi-
vocally identified, because TMSbCl2 is eluted in the void
volume. So far signals for TMSbCl2 can only be obtained using
anion-exchange chromatography, giving rise to very broad
peaks and unfavourable separations, otherwise it is eluted in
the void volume.1
Results and discussion
This study has been devoted to the development of reliable
speciation procedures for the determination of Sb compounds
in urine by HPLC-ICP-MS. Total Sb concentrations in urine of
occupationally non-exposed adults are very low and range
from 0.19 to 1.1 mg l21.9 In a previous study we established
even lower Sb concentrations, i.e., a median of 0.06 mg l21
Table 1 Operating conditions for HPLC-ICP-MS with ultrasonic
nebulisation or hydride generation
HPLC:
Anion exchange columns Dionex IonPac AS 14, 250 mm6
4 mmzDionex IonPac AG 14,
4 mm (10–32), Dionex Corporation,
Sunnyvale, CA, USA. Hamilton
PRP-X100, 250 mm64 mmz
guard column PRP 1, Reno,
NE, USA
ION-120, 120 mm64.6 mmzguard
column, Cetac Technologies,
Division of Transgenomics, Omaha,
NE, USA
Flow rate 1.5 ml min21
Injection volume 100 ml
Ultrasonic nebulization:
Nebulizer U-6000ATz (Cetac Technologies,
Omaha, NE, USA)
Sweep gas (argon) 2.35 l min21
Heating temperature 80 ‡C
Desolvation temperature 80 ‡C




0.6% (w/v), stabilised with 0.04%
(w/v) NaOH
NaBH4 solution flow rate 4 ml min
21
HCl solution concentration 0.5% (w/v)
HCl solution flow rate 6 ml min21
Carrier gas flow rate Argon, 50 ml min21
ICP-MS:
Forward Power 1200 W
Cones Nickel
Plasma gas 15.0 l min21
Nebulizer gas #1.0 l min21, daily optimised
to obtain maximum 121Sb(V)
signal intensity
Auxiliary gas #1.0 l min21 daily optimized to
obtain maximum 121Sb(V) signal
intensity
Data acquisition 121Sb, peak hoping mode, replicate
time 1 s, dwell time 20 ms, 50 sweeps
per reading, 1 reading per replicate
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(range: v0.01 to 0.53 mg l21), in the urine of 30 school children
by USN-ICP-MS.10 In the urine of workers occupationally
exposed to Sb compounds (mainly to Sb2O3 and SbH3)
distinctly elevated Sb levels (normally 5 to 10 mg l21, up to
several hundreds of mg l21) have been determined.11 Therefore,
HPLC-ICP-MS, providing the lowest detection limits currently
available for Sb speciation,5,6 was used for the development of
Sb speciation procedures in urine.
Method development
Preliminary experiments with HPLC-USN-ICP-MS. Initial
attempts to determine Sb species in urine obtained by plain
1z9 dilution with high-purity water or with the employed
mobile phase (1.25 mM EDTA) on the Dionex AS14 column
yielded insufficiently-reproducible chromatograms containing
several peaks. Firstly, these peaks could not be identified by
comparing their retention times with those of aqueous Sb(V)
and Sb(III) standards [Fig. 1(a)]. Spiking of the urine samples
with adequate amounts of Sb(V) and Sb(III) revealed that both
Sb peaks were seriously broadened and, as a more severe
problem, that the Sb(III) peak was distinctly shifted to longer
retention times. Besides, additional peaks which could not be
identified occurred in the chromatograms [Fig. 1(b)–(d)].
As the chromatographic separation of Sb(V) and Sb(III) is
based on anion-exchange chromatography, it was assumed that
the high concentration of sodium chloride present in the urine
(physiological NaCl concentration 0.9%), in particular the high
chloride concentration, might hamper the chromatographic
separation of the anions. It should be noted that Sb(V) is
mononegatively charged in aqueous solutions of pH 2.7 to 10.4
whereas Sb(III) is not charged. Thus, a conversion of Sb(III) to a
soluble, stable, negatively charged complex, for example by
reaction with EDTA, phthalic or tartaric acids, is desirable for
retaining Sb(III) on an anion-exchange column.
To investigate the potential influence of the high sodium
chloride concentration in urine on the chromatographic
separation, various amounts of NaCl (0.05–0.2%) were
dissolved in 1.25 mM EDTA, which served as mobile phase.
Higher NaCl concentrations were not studied because
chromatograms had already shown strong signal depression
and unacceptable separation with 0.2% NaCl. The results can
be summarised as follows [Fig. 1(b)–(d)]. (1) The sharp peak
eluting with the solvent front can be attributed to the elution of
sodium present in the urine [Fig. 1(b)]. Sodium as a cation is
obviously eluted in the void volume of the anion-exchange
column, a fact that can also be easily detected by the colour of
the inner plasma region turning to yellow when Na elutes. The
peak height increased with increasing NaCl concentration in
the investigated synthetic solutions. (2) With increasing NaCl
concentration, the Sb(III) peak was shifted to longer retention
times, whereas the retention time of the Sb(V) peak remained
constant. Both Sb signals in Fig. 1(b) represent blank levels of
Sb(V) and Sb(III) in NaCl of the highest commercially available
purity (0.05% solution). However, both peaks distinctly
broadened with increasing NaCl concentration. At an NaCl
concentration of 0.2%, Sb(V) co-eluted with the Na-induced
peak and the Sb(III) peak split into two broad peaks starting at
650 s and covering a retention time of 500 s. (3) Addition of
standard solutions containing Sb(V) and Sb(III) to the sodium
chloride test solutions revealed that signals for both Sb species
were severely suppressed by the NaCl matrix in comparison to
the peak areas obtained from aqueous standard solutions. For
a comparison, the different concentrations of the Sb(III) and
Sb(V) standard solutions—as specified in detail in the figure
legend—as well as the different scale of the y axis have to be
considered. (4) The occurrence of additional peaks in the
chromatograms could not be reproduced easily and was
strongly dependent on the spiked or natural concentration of
Sb(V) and Sb(III) present in the urine [Fig. 1(d)].
Matrix separation. It was evident from the results of the
aforementioned experiments that the NaCl matrix is respon-
sible for at least some of the problems initially observed in the
speciation of Sb in urine by HPLC-ICP-MS. The involvement
of chloride in the chromatographic separation of Sb(V) and
Sb(III) could be experimentally proven by simultaneous
monitoring of the ICP-MS signal at m/z 37 (37Cl). The 37Cl
intensity always increased when one of the unknown peaks
shown in Fig. 1(b)–(d) appeared in the chromatograms.
Consequently, a procedure to eliminate or to reduce the
NaCl-based interferences had to be developed. The ‘‘classical’’
precipitation of chloride as AgCl was tested for its suitability in
reducing the chloride concentration in urine thoroughly.
Fig. 1 Experimental conditions. HPLC: mobile phase 1.25 mM EDTA,
pH 4.7; column Dionex AS14; detection: USN-ICP-MS. (a) Chroma-
togram of 50 ng l21 of each Sb(V) and Sb(III). (b) Chromatogram of a
0.05% NaCl solution in 1.25 mM EDTA (mobile phase). (c)
Chromatogram (b) spiked with 1 mg l21 of each Sb(V) and Sb(III). (d)
Chromatogram of a urine sample diluted 1z4 with 1.25 mM EDTA
and spiked with 1 mg l21 of each Sb(V) and Sb(III).
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Therefore, AgNO3 was added to the diluted urine samples until
the precipitation of chloride was finished. Urine samples were
then passed through 0.2 mm filters and subsequently analysed for
Sb species by HPLC-USN-ICP-MS. In fact, the diminished
concentration of chloride in the diluted urine samples changed the
elution profile of both Sb and Cl species dramatically [Fig. 2(a)].
Sb(V) and Sb(III) co-eluted under these conditions, and the
chloride trace in Fig. 2(a) indicates that the major amount of
chloride was eluted after Sb(III). The chloride signal remained,
without AgNO3 addition, at baseline level during the elution of
Sb(V) and only increased when Sb(III) was eluted [Fig. 2(b)]. At
higher Sb(III) concentrations in urine, the Sb(III) peak divided into
two peaks and similarly also the chloride pattern changed
[Fig. 2(c)]. Obviously, competition between the formation of Sb-
chloride and Sb-EDTA complexes led to these two Sb(III) peaks,
and was in general responsible for the bad peak shapes of the
chromatograms. Similarly, the significant tailing of the Sb(V) peak
[Fig. 2(b) and (c)] or fractionation [Fig. 1(d)] can be attributed to
the same complexation. Overall, an acceptable chromatographic
separation of Sb(V) and Sb(III) was not possible under all
aforementioned conditions.
Therefore,anotheranion-exchangechromatographicseparation
of Sb(V) and Sb(III) with the PRP-X100 column was tested, which
has been already successfully applied within a HPLC-HG-AAS set-
up.4 Compared to the previous separation with the Dionex AS14
column, the EDTA concentration in the mobile phase of the
separation using the Hamilton PRP-X100 column was increased
from 1.25 mM to 20 mM, thus favouring the formation of an Sb-
EDTA complex. Stable signals of well-shaped peaks for both Sb(V)
and Sb(III) were thus obtained. However, the Na-induced peak
appearing at the solvent front, which had been already observed
when using the Dionex AS14 column, was still noticed. Because
Sb(V) eluted during the separation with the PRP-X100 column near
the solvent front, the Na-induced peak and Sb(V) co-eluted.
Consequently, quantification of Sb(V) was not easily achievable. In
order to avoid the occurrence of the ‘‘Na-peak’’ in the void volume,
the use of hydride generation was considered to convert the eluted
Sb species into their volatile hydrides.
As well as analysing aqueous standard solutions, the Dionex
column provides two important advantages over the Hamilton
column: (a) Sb(V) is eluted in the void volume of the Hamilton
PRP-X100 column, whereas Sb(V) is retained on the Dionex
column; and (b) the concentration of EDTA in the mobile
phase is 20 mM for the separation of Sb(V) and Sb(III) with the
PRP-X100 column, whereas only 1.25 mM are needed when
using the Dionex column. The reduced amount of EDTA
needed with the Dionex column leads to a lower baseline in the
chromatograms and to better signal-to-noise ratios.
HPLC-HG-ICP-MS. For the coupling of HPLC to hydride
generation (HG)-ICP-MS, the USN was replaced by the
HG-system. Identical parameters (NaBH4 and HCl concentra-
tions, flow rates, gas pressure), as optimised in previous work for
HPLC-HG-AAS,4 proved to give best results also for HPLC-HG-
ICP-MS and were thus used throughout all further investigations.
As expected, the Na-induced peak in the void volume of the PRP-
X100 column disappeared, allowing the quantification of Sb(V)
[Fig. 3(a)]. Signals for Sb(III) were higher than for Sb(V), due to the
preferred kinetics of Sb(III) during hydride generation. When
analysing urine samples, Sb(III) was slightly shifted to earlier
retention times compared to standard solutions. Nevertheless,
peaks for Sb(III) retained their good peak shape and the shifting
effect could be avoided when an injection of a urine sample onto
the column was made about every 12 min. The PRP-X100 column
did not suffer from performance loss, even when urine samples
were diluted only 1z2. To keep the dilution factor as low as
possible, this 1z2 dilution has been routinely applied in the
analysis of Sb(V) and Sb(III) in urine samples.
TMSbCl2 cannot be eluted under the aforementioned chroma-
tographic conditions, as alkaline pH values are required for that
purpose. The ION-120 anion-exchange column provided a good
separation between TMSbCl2 and Sb(V) using 2 mM NH4HCO3
and 1 mM tartaric acid at pH 8.5 as mobile phase within less than
3 min [Fig. 4(a)]. When this chromatographic separation was
applied to urine samples, severe peak broadening of Sb(V), but not
of TMSbCl2, was observed [Fig. 4(b) and (c)]. As Sb(V) can easily
be determined in the set-up with the PRP-X100 column, the broad
Sb(V) peak would only hamper the determination of TMSbCl2
when urinary concentrations of Sb(V) exceed approximately
5 mg l21, which is normally not the case.
Analytical characterisation
The two successfully applied chromatographic separations
using the PRP-X100 and ION-120 columns were thoroughly
evaluated for their analytical performances, including the
calculation of limits of detection (LOD) for all three
investigated Sb species. To this end, at least 10 aliquots of
standard solutions at low concentrations of the analytes
[0.1 mg l21 of each TMSbCl2 and Sb(III), 0.2 mg l
21 of Sb(V)]
were repetitively injected onto the columns. LODs were
calculated from 3 times the standard deviation of the mean
Fig. 2 Experimental conditions. HPLC: mobile phase 1.25 mM EDTA,
pH 4.7; column Dionex AS14; detection: USN-ICP-MS. Monitored
signals: m/z 121 (Sb), bold lines and m/z 37 (Cl), dotted lines. (a)
Chromatogram of a urine sample diluted 1z9 with 1.25 mM EDTA
followed by precipitation of chloride with AgNO3. (b) Chromatogram
of the urine sample in (a) after plain dilution with 1.25 mM EDTA and
spiking with 1 mg Sb(V) l21. (c) Chromatogram of the urine sample in
(a) after plain dilution with 1.25 mM EDTA and spiking with
2 mg Sb(III) l21.
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value of the thus obtained peak areas divided by the slope of
the calibration curve. These investigations were carried out in
solutions prepared from dilution of Sb stock standard solutions
with the employed mobile phases, or by dilution of the
standard solutions with 1z2 diluted urine. For the developed
HPLC-HG-ICP-MS procedure, detection limits in the low
ng l21 range for all three Sb species, as specified in detail in
Table 2, could be achieved. These LODs are comparable to
those already obtained with an HPLC-USN-ICP-MS set-up
and are about 100 times lower than LODs for HPLC-HG-AAS
(Table 2). Although LODs for both ICP-MS approaches are
similar, it should be stressed that the use of hydride generation
allows the quantification of Sb compounds in urine, which is
rather difficult, if not impossible, to realise by using the
USN. Moreover, HG is much cheaper than USN. The
reproducibility of repetitive injections/quantifications at the
aforementioned concentrations levels of the analytes in the
1z2 diluted urine matrix ranged from 2.7% for Sb(III) to 5%
for TMSbCl2. For standard solutions the corresponding values
amounted to approximately 3%. The slope of the calibration
curves was equal for Sb(III), no matter whether standards were
prepared with the mobile phase or with 1z2 diluted urine. On
the contrary, sensitivities, i.e., peak areas, for Sb(V) and
TMSbCl2 changed slightly depending on the urine matrix. In
general, peak areas for Sb(V) and TMSbCl2 were approxi-
mately 10 to 20% (depending on the urine matrix) lower in 1z2
diluted urine when compared to the peak areas obtained from
standards prepared with the employed mobile phase. There-
fore, quantification of all analytes was carried out by standard
additions.
Fig. 3 Experimental conditions. HPLC: mobile phase 20 mM EDTA,
pH 4.7; column Hamilton PRP-X100; detection: HG-ICP-MS. (a)
Chromatogram of a standard solution containing 1 mg l21 of both
Sb(V) and Sb(III). (b) Chromatogram of the Seronorm reference urine
diluted 1z49. (c) Chromatogram of the urine from (b) spiked with
1 mg Sb(V) l21 and 0.1 mg Sb(III) l21.
Fig. 4 Experimental conditions. HPLC: mobile phase 2 mM NH4HCO3
and 1 mM tartaric acid, pH 8.5; column ION-120; detection: HG-ICP-
MS. (a) Chromatogram of a standard solution of 100 ng l21 TMSbCl2 and
200 ng l21 Sb(V). (b) Chromatogram of a 1z4 diluted urine sample of an
exposed person. (c) Chromatogram of the urine sample in (b) spiked with
250 ng l21 Sb(V).
Table 2 Comparison of limits of detection (mg l21Sb) for Sb(V), Sb(III)
and TMSbCl2 using different spectrometric detection devices
Sb(V) Sb(III) TMSbCl2 Reference
Detection
HG-AAS 1.0 0.7 0.4 4
USN-ICP-MS 0.012 0.014 0.009 6
HG-ICP-MS 0.020 0.008 0.012 This work
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Speciation analysis of urinary Sb compounds
The developed HPLC-HG-ICP-MS procedure was applied to
the determination of Sb(V), Sb(III) and TMSbCl2 in selected
urine samples. The corresponding results are summarised in
Table 3. Total Sb concentrations in urine were determined by
HG-AAS. All results are based on at least 3 independent
determinations. In the two urine samples of non-exposed
subjects, the total Sb concentration was below the method
detection limit of 0.12 mg Sb l21. Concentrations for Sb(V) and
Sb(III) were also below the method detection limits, except for
TMSbCl2, which was found in ultratrace amounts in one
sample (Table 3). Total Sb urine concentrations of two persons
working in the lead battery producing industry were about 100
times higher than for non-exposed persons. These workers are
exposed to antimony trioxide and stibine (SbH3). Surprisingly
Sb(V), but not Sb(III), followed by TMSbCl2 were the
predominant Sb species determined in the two urine samples.
Sb(III), if detectable, was only present at very low concentra-
tions (Table 3). As Sb(III) is known to exert a 10-times higher
toxicity than Sb(V), it seems that the human body can detoxify
Sb(III) by oxidation to Sb(V), and possibly biomethylates Sb(III)
and/or Sb(V) to TMSbCl2. The biomethylation of both Sb(III)
and Sb(V) by microorganisms and by fungi cultures of
Scopulariopsis brevicaulis has been established experimentally
during recent years.1,12–14 Additionally, an unknown Sb species
was detected in the urine of one exposed person [Fig. 4(b) and
(c)]. Assuming an identical slope for the calibration of this
compound as established for Sb(V), the concentration of this Sb
compound amounts to 0.13 mg l21.
In the NIST urine reference material, TMSbCl2 was the most
abundant species with traces of Sb(III). Antimony added
(100 mg l21) to the Seronorm urine reference urine was spiked by
the manufacturer as Sb(V) [Fig. 3(b) and (c)]. The highest amount
(1.7¡0.4 mg l21) of Sb(III) by far was identified in the Seronorm
urine. TMSbCl2 was not quantified in this sample because its
determination was severely hampered by the extraordinarily high
concentration of Sb(V) that had been added to the urine by the
manufacturer. Generally, in non-spiked urine samples, the sum of
the concentrations of Sb(V), Sb(III) and TMSbCl2 ranged between
51 and 78% of the total Sb concentrations.
Conclusions
The high chloride concentration in urine can severely hamper the
chromatographic separation of Sb(V) and Sb(III) by anion-
exchange chromatography, especially that of Sb(III). The applied
separation principle is based upon the in situ conversion of Sb(III)
in urine, which is associated with chloride, into its corresponding
EDTA-complex. Therefore, increasing the concentration of the
complexing agent, i.e., EDTA, in the mobile phase will enhance
the stability and reproducibility of the separation of Sb(V) and
Sb(III). Thus the chromatographic separation of Sb(V) and Sb(III)
on the PRP-X100 column involving 20 mM EDTA at pH 4.7 is
superior to that on the Dionex AS14 column with 1.25 mM
EDTA at pH 4.7 as mobile phase when analysing matrices with
high chloride content.
Sodium eluting in the void volume of the anion-exchange
columnsgives rise toaNa-inducedpeakwhichoverlapswithsignals
of Sb species eluting in or near [Sb(V) on the PRP-X100 column] the
void volume. To overcome this problem, hydride generation can be
successfully employed, which adds further selectivity by converting
only hydride-forming species into volatile compounds. Thus only
hydride-forming Sb species can be detected by this approach. But
Zhengetal.15demonstratedrecentlythatat leastfournon-identified
Sb species are HG-active besides Sb(III), Sb(V) and TMSbCl2.
This first study on the elucidation of Sb species in urine
indicates that people exposed to Sb(III) metabolise Sb(III) in the
body mainly to Sb(V) as well as to TMSbCl2, thus detoxifying
the 10-times more harmful Sb(III). Although, generally, much
more than 50% of the total Sb can be attributed to the
investigated Sb species, further studies are needed to identify
the remaining currently non-identified Sb species in urine.
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Table 3 Concentrations of total Sb and of Sb species (mg l21Sb) in urine samples of occupationally exposed and non-exposed subjects and in two
lyophilised urine reference materials as determined by HG-AAS and HPLC-HG-ICP-MS
Samples
Total Sb concentration Speciation analysis
Experimental value, n~5 Sb(V) Sb(III) TMSbCl2 Sum of species Recovery (%)
Non-exposed person A v0.12 v0.060 v0.025 v0.036 v0.12 —
Non-exposed person B v0.12 v0.060 v0.025 0.09¡0.02 v0.18 —
Exposed person A 8.3¡0.3a 5.9¡0.2 0.15¡0.05 0.40¡0.04 6.45 78
Exposed person B 5.1¡0.4a 2.0¡0.1 v0.025 0.57¡0.07 2.60 51
NIST SRM 2670 0.53¡0.05b v0.060 0.07¡0.02 0.23¡0.03 0.36 68
Seronorm 403125 104¡3c 101¡0.5 1.7¡0.4 —d 102.7 99
aResults confirmed by independent analysis of the urine samples at the Institute of Environmental and Occupational Health, University of
Erlangen-Nu¨rnberg, Germany. bNo certified value available, concentration determined in a previous study using USN-ICP-MS (ref. 10).
c100 mg Sb l21 added by the manufacturer. dNot determined (see also text).
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